Does the traditional snakebite severity score correctly classify envenomated patients?.
- Author:
Seungho KANG
1
;
Jeongmi MOON
;
Byeongjo CHUN
Author Information
- Publication Type:Original Article
- Keywords: Snakes; Venoms; Antivenins
- MeSH: Antivenins; Hospitalization; Humans; Prothrombin; Prothrombin Time; Retrospective Studies; Rhabdomyolysis; Sensitivity and Specificity; Snake Bites*; Snakes; Venoms
- From: Clinical and Experimental Emergency Medicine 2016;3(1):34-40
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: This study aims to help set domestic guidelines for administration of antivenom to envenomated patients after snakebites. METHODS: This retrospective observational case series comprised 128 patients with snake envenomation. The patients were divided into two groups according to the need for additional antivenom after the initial treatment based on the traditional snakebite severity grading scale. One group successfully recovered after the initial treatment and did not need any additional antivenom (n=85) and the other needed an additional administration of antivenom (n=43). RESULTS: The group requiring additional administration of antivenom showed a higher local effect score and a traditional snakebite severity grade at presentation, a shorter prothrombin and activated partial prothrombin time, a higher frequency of rhabdomyolysis and disseminated intravascular coagulopathy, and longer hospitalization than the group that did not need additional antivenom. The most common cause for additional administration was the progression of local symptoms. The independent factor that was associated with the need for additional antivenom was the local effect pain score (odds ratio, 2.477; 95% confidence interval, 1.309 to 4.689). The optimal cut-off value of the local effect pain score was 1.5 with 62.8% sensitivity and 71.8% specificity. CONCLUSION: When treating patients who are envenomated by a snake, and when using the traditional snakebite severity scale, the local effect pain score should be taken into account. If the score is more than 2, additional antivenom should be considered and the patient should be frequently assessed.
